Insider Transactions Reported by 11 Insiders of NeuBase Therapeutics, Inc.

Location
Pittsburgh, PA

There are no Buy or Sell transactions made by insiders since 30 Dec 2024

NeuBase Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Symetryx Corp 10%+ Owner $369,564 14 Sep 2023
Dietrich A. Stephan Founder and CEO, Director, 10%+ Owner $301,294 02 Aug 2023
Todd P. Branning Chief Financial Officer $161,664 16 Mar 2023
ERIC I. RICHMAN Director $139,597 09 Sep 2022
William Mann Chief Operating Officer $21,504 30 Mar 2022
Kianoush Motesharei Officer 24 May 2021
Sandra Rojas-Caro Chief Medical Officer 24 Jan 2022
J. McDougall Director 09 Sep 2022
FRANKLYN G. PRENDERGAST Director 09 Sep 2022
GOLDSTEIN DOV A MD Director 09 Sep 2022
Eric J. Ende Director 09 Sep 2022

Recent Insider Transactions by Companies or Individuals for NeuBase Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.